C81.76 Other Hodgkin lymphoma, intrapelvic lymph nodes

Name of the Condition

• Other Hodgkin lymphoma, intrapelvic lymph nodes (ICD Code: C81.76)

Summary

Other Hodgkin lymphoma, intrapelvic lymph nodes is a subtype of Hodgkin lymphoma characterized by the presence of Reed-Sternberg cells, with abnormal cell growth occurring in the lymph nodes located within the pelvic region. This condition represents a localized anatomical presentation of Hodgkin lymphoma, distinct from other subtypes affecting different lymph node groups or sites.

Causes

The exact cause of Hodgkin lymphoma, including subtypes affecting specific lymph node regions, is not fully understood. It is believed to involve a combination of genetic factors and environmental exposures. Viral infections, such as Epstein-Barr virus, have been associated with some cases, though not all.

Risk Factors

• Age: Most common in young adults (15-35) and older adults (over 55).
• Family history of lymphoma.
• Weakened immune system (e.g., from HIV/AIDS or immunosuppressive therapy).
• Prior infection with Epstein-Barr virus.

Symptoms

• Painless swelling of lymph nodes in the pelvic region.
• Persistent fatigue.
• Fever, chills, or night sweats.
• Unexplained weight loss.
• Itching (pruritus).

Diagnosis

Diagnosis typically involves a physical examination to assess lymph node enlargement, imaging tests (e.g., CT or PET scans) to evaluate the extent of pelvic lymph node involvement, and a biopsy of an affected lymph node to confirm the presence of Reed-Sternberg cells. Additional tests may include blood work to assess overall health and detect abnormalities.

Treatment Options

Treatment may include chemotherapy, radiation therapy, or a combination of both, depending on the stage and extent of the disease. Targeted therapies or immunotherapy may also be considered in certain cases. Treatment plans are individualized based on the patient's overall health and specific disease characteristics.

Prognosis and Follow-Up

The prognosis for other Hodgkin lymphoma, intrapelvic lymph nodes, depends on factors such as the stage at diagnosis, response to treatment, and overall health. Early detection and treatment generally improve outcomes. Follow-up care typically involves regular monitoring with physical exams, imaging, and blood tests to check for recurrence or complications.

Complications

Potential complications may include treatment-related side effects (e.g., fatigue, nausea, or infection risk from chemotherapy), lymphedema, or long-term effects of radiation therapy. In some cases, the disease may progress or recur, requiring additional treatment.

Lifestyle & Prevention

While specific prevention strategies for Hodgkin lymphoma are not well-established, maintaining a healthy immune system through balanced nutrition, regular exercise, and avoiding known risk factors (e.g., smoking) may support overall health. Avoiding exposure to known environmental triggers, when possible, is also advisable.

When to Seek Professional Help

Seek medical attention if you experience persistent, unexplained swelling of pelvic lymph nodes, unexplained weight loss, fever, night sweats, or fatigue. Early evaluation is important for accurate diagnosis and timely treatment.

Tips for Medical Coders

When coding for other Hodgkin lymphoma, intrapelvic lymph nodes (C81.76), ensure the documentation specifies the anatomical location (intrapelvic lymph nodes) to support the code assignment. Verify that the diagnosis aligns with the presence of Reed-Sternberg cells and exclude other lymphoma subtypes or non-Hodgkin lymphoma. Accurate coding requires clear documentation of the affected lymph node region and histologic confirmation.